U.S. Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Software
CSP Inc (CSPI) Reports Q3 2024 Earnings: EPS of -$0.02, Revenue at $13.1 Million
Service Revenue Grows 10% Driving Continued Gross Margin Percentage; Near-record Cash Position Achieved While Continuing Infrastructure Buildout Supporting AZT PROTECT™ Market Penetration Aug 13, 2024
GuruFocus Research Biotechnology
UroGen Pharma Ltd (URGN) Q2 2024 Earnings: EPS Misses Estimates at -$0.91, Revenue Falls Short at $21.8 Million
UroGen Pharma Ltd (URGN) released its 8-K filing on August 13, 2024, detailing its financial performance for the second quarter ended June 30, 2024. Aug 13, 2024